Geode Capital Management LLC Buys 194,776 Shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM)

Geode Capital Management LLC increased its stake in shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) by 1,267.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 210,144 shares of the company’s stock after purchasing an additional 194,776 shares during the quarter. Geode Capital Management LLC owned about 0.61% of Monogram Orthopaedics worth $557,000 at the end of the most recent quarter.

Separately, State Street Corp bought a new stake in shares of Monogram Orthopaedics during the third quarter valued at approximately $62,000. Institutional investors own 0.45% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Roth Capital raised shares of Monogram Orthopaedics to a “strong-buy” rating in a research note on Monday, December 9th. Roth Mkm assumed coverage on shares of Monogram Orthopaedics in a research note on Monday, December 9th. They issued a “buy” rating and a $4.00 price objective on the stock.

Monogram Orthopaedics Stock Performance

Shares of MGRM stock opened at $2.50 on Friday. Monogram Orthopaedics, Inc. has a 52-week low of $1.53 and a 52-week high of $4.90. The stock has a market cap of $85.78 million, a PE ratio of -5.32 and a beta of 1.51. The firm’s 50 day moving average price is $2.34 and its two-hundred day moving average price is $2.46.

Monogram Orthopaedics Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.